NewsBenzingaLes principaux prévisionnistes de Wall Street révisent leurs attentes sur Cardinal Health avant les résultats du troisième trimestre. Les principaux prévisionnistes de Wall Street révisent leurs attentes sur Cardinal Health avant les résultats du troisième trimestre. Benzinga 2026.11.05 08:20 (GMT+0) Open on Benzinga Other news Karyopharm Therapeutic Common Shares To Be Suspended, Effective Nov. 11; To Trade On OTC Under KPTIQ Ticker Cantor Fitzgerald Maintains Overweight on Hut 8, Lowers Price Target to $127 Why Is Joby Aviation Stock Surging Thursday? HubSpot Analysts Slash Their Forecasts After Q3 Results Wall Street's Most Accurate Analysts Spotlight On 3 Energy Stocks Delivering High-Dividend Yields Global Payments Lowers FY2026 GAAP EPS Guidance from $(3.85)-$(3.77) to $(3.90)-$(3.81) vs $(2.94) Est; Lowers FY2026 Sales Guidance from $13.100B-$13.177B to $12.946-$13.023
Karyopharm Therapeutic Common Shares To Be Suspended, Effective Nov. 11; To Trade On OTC Under KPTIQ Ticker
Global Payments Lowers FY2026 GAAP EPS Guidance from $(3.85)-$(3.77) to $(3.90)-$(3.81) vs $(2.94) Est; Lowers FY2026 Sales Guidance from $13.100B-$13.177B to $12.946-$13.023
